Mark A. Smith

Q: What Schools Are Affiliated With Mark A. Smith

Mark A. Smith is affiliated with the following schools: University of Utah, University of California, Berkeley, University of St Andrews, University of Strathclyde, University of Nottingham, University of Dundee, Edith Cowan University, Durham University, University of Edinburgh, Stanford University, Case Western Reserve University, Asahikawa Medical College

Mark A. Smith's AcademicInfluence.com Rankings

Mark A. Smith

Biology

#1279

World Rank

#2171

Historical Rank

#650

USA Rank

Neuroscience

#354

World Rank

#371

Historical Rank

#124

USA Rank

biology Degrees

Download Badge

Biology

Mark A. Smith's Degrees

PhD Neuroscience Stanford University

Why Is Mark A. Smith Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Mark Anthony Smith was a professor of pathology at Case Western Reserve University in Cleveland, Ohio, where he also served as the Director of Basic Science Research at the University Memory and Aging Center. At the time of his death, he had been serving as Executive Director of the American Aging Association.

(See a Problem?)

Mark A. Smith's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes (2008) (2360)
Alzheimer disease. (2010) (1859)
Oxidative Damage Is the Earliest Event in Alzheimer Disease (2001) (1811)
Mitochondrial abnormalities in Alzheimer disease (2000) (1275)
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease (1997) (1246)
4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease (1997) (990)
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease (2009) (981)
Oxidative stress and neurotoxicity. (2008) (740)
RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease (1999) (721)
Drosophila Fragile X-Related Gene Regulates the MAP1B Homolog Futsch to Control Synaptic Structure and Function (2001) (656)
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. (2010) (610)
Involvement of Oxidative Stress in Alzheimer Disease (2006) (556)
Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress (1998) (553)
Comparative genome sequencing of Drosophila pseudoobscura: chromosomal, gene, and cis-element evolution. (2005) (548)
Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. (2003) (525)
In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease (2000) (512)
Radical AGEing in Alzheimer's disease (1995) (475)
Oxidative stress in Alzheimer disease: A possibility for prevention (2010) (446)
Alzheimer's disease: the two-hit hypothesis (2004) (417)
Alzheimer Disease and Oxidative Stress (2002) (414)
Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide (1995) (414)
Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease (2001) (409)
Oxidative stress signalling in Alzheimer's disease (2004) (393)
Oxidative Stress Increases Expression and Activity of BACE in NT2 Neurons (2002) (368)
Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* (2000) (361)
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. (2010) (350)
Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease (2000) (345)
The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease (2002) (345)
Role of mitochondrial dysfunction in Alzheimer's disease (2002) (344)
Redox-active iron mediates amyloid-β toxicity (2001) (340)
Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. (2004) (320)
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease (2003) (316)
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis (2001) (302)
Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? (2002) (302)
Oxidative Stress and Neurodegeneration (2005) (300)
Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. (2003) (290)
Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein (2007) (283)
Modulation of Hippocampal Plasticity and Cognitive Behavior by Short-term Blueberry Supplementation in Aged Rats (2004) (283)
Microglial activation and amyloid‐β clearance induced by exogenous heat‐shock proteins (2002) (279)
Systemic Increase of Oxidative Nucleic Acid Damage in Parkinson's Disease and Multiple System Atrophy (2002) (279)
Alzheimer disease, the two-hit hypothesis: an update. (2007) (274)
Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron* (2005) (270)
Role of metal dyshomeostasis in Alzheimer's disease. (2011) (265)
The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease (2009) (257)
Mitochondria: a therapeutic target in neurodegeneration. (2010) (253)
Abnormal mitochondrial dynamics and neurodegenerative diseases. (2010) (252)
Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease (1998) (246)
Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion (2011) (243)
Oxidative stress in diabetes and Alzheimer's disease. (2009) (243)
Tau phosphorylation in Alzheimer's disease: pathogen or protector? (2005) (232)
Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine (1998) (230)
Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease (1995) (227)
Diabetes‐induced nitrative stress in the retina, and correction by aminoguanidine (2002) (221)
Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. (2010) (209)
Oxidative Stress and Redox‐Active Iron in Alzheimer's Disease (2004) (207)
Copernicus revisited: amyloid beta in Alzheimer’s disease (2001) (202)
Identification of Ubiquilin, a Novel Presenilin Interactor That Increases Presenilin Protein Accumulation (2000) (201)
In Alzheimer's Disease, Heme Oxygenase Is Coincident with Alz50, an Epitope of τ Induced by 4‐Hydroxy‐2‐Nonenal Modification (2000) (200)
A zyxin-mediated mechanism for actin stress fiber maintenance and repair. (2010) (200)
Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease? (2011) (198)
Nucleic acid oxidation in Alzheimer disease. (2008) (196)
Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. (2012) (195)
The up‐regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α (2009) (193)
Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease (2012) (191)
Overexpression of Heme Oxygenase in Neuronal Cells, the Possible Interaction with Tau* (2000) (190)
Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. (2008) (187)
Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine (2001) (186)
Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease. (1998) (186)
Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease (2007) (184)
Challenging the Amyloid Cascade Hypothesis: Senile Plaques and Amyloid‐β as Protective Adaptations to Alzheimer Disease (2004) (183)
Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein (2001) (182)
Vascular oxidative stress in Alzheimer disease (2007) (180)
Tau – an inhibitor of deacetylase HDAC6 function (2009) (179)
Amyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain (2002) (176)
Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. (2006) (176)
The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations (2011) (175)
From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). (2008) (175)
Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. (2006) (173)
The Role of Oxidative Stress in the Pathophysiology of Cerebrovascular Lesions in Alzheimer's Disease (2002) (173)
Abnormal localization of iron regulatory protein in Alzheimer's disease (1998) (172)
Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. (2007) (171)
Alzheimer Disease Pathology As a Host Response (2008) (168)
Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. (2007) (168)
Faculty of 1000 evaluation for Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. (2012) (167)
Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35 (2010) (163)
Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans (2002) (163)
Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance (2006) (163)
Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. (2007) (159)
Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? (2003) (158)
Oxidative Damage to RNA in Aging and Neurodegenerative Disorders (2012) (157)
Abortive apoptosis in Alzheimer's disease (2001) (156)
Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. (2007) (155)
Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. (2009) (155)
Alzheimer disease and the role of free radicals in the pathogenesis of the disease. (2008) (154)
Insulin is a two-edged knife on the brain. (2009) (154)
Metal ions and oxidative protein modification in neurological disease. (2005) (153)
Hippocampal vulnerability to stress and aging: possible role of neurotrophic factors (1996) (153)
Advanced Maillard Reaction End Products, Free Radicals, and Protein Oxidation in Alzheimer's Disease a (1994) (153)
4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. (2005) (153)
Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 Caucasian women. (1990) (151)
RNA oxidation in Alzheimer disease and related neurodegenerative disorders (2009) (151)
LIPID PEROXIDATION AND PROTEIN OXIDATION IN ALZHEIMER'S DISEASE BRAIN: POTENTIAL CAUSES AND CONSEQUENCES INVOLVING AMYLOID -PEPTIDE-ASSOCIATED FREE RADICAL OXIDATIVE STRESS (2002) (149)
Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. (1982) (149)
Antioxidant therapy in Alzheimer's disease: theory and practice. (2008) (149)
Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. (1986) (148)
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation (2012) (147)
Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. (2005) (146)
Activation of MKK6, an upstream activator of p38, in Alzheimer's disease (2001) (145)
Senile plaque composition and posttranslational modification of amyloid-β peptide and associated proteins (2002) (144)
Increased Autophagic Degradation of Mitochondria in Alzheimer Disease (2007) (142)
Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses (2007) (142)
Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells (2010) (140)
A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. (2010) (140)
Oxidative imbalance in alzheimer’s disease (2007) (140)
Nanoparticle and other metal chelation therapeutics in Alzheimer disease. (2005) (139)
Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease. (2013) (138)
Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. (2002) (138)
Iron: A Pathological Mediator of Alzheimer Disease? (2002) (138)
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease (2009) (136)
Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease (2009) (135)
Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. (2008) (135)
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease (2004) (135)
Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. (2009) (133)
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes (2008) (132)
Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. (2005) (131)
Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells (2003) (131)
Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease (2008) (130)
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic (2006) (128)
Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells. (2008) (128)
High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal* (2002) (127)
Cl−-ATPase and Na+/K+-ATPase activities in Alzheimer's disease brains (1998) (127)
Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats (2008) (126)
Introduction of fast MR imaging in the assessment of hepatic steatosis (1997) (126)
Leptin: a novel therapeutic strategy for Alzheimer's disease. (2009) (124)
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. (2005) (124)
Oxidative Damage to RNA in Neurodegenerative Diseases (2006) (123)
Early amyloid accumulation in the hippocampus of SAMP8 mice. (2010) (123)
Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology (2002) (123)
Klf15 orchestrates circadian nitrogen homeostasis. (2012) (121)
Absence of cellular stress in brain after hypoxia induced by arousal from hibernation in Arctic ground squirrels. (2005) (121)
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease (2010) (120)
Oxidative damage in Alzheimer’s disease: the metabolic dimension (2000) (119)
Free radical damage, iron, and Alzheimer's disease (1995) (119)
Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease (2004) (118)
Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. (2010) (118)
Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is ‘too big to fail’ (2011) (117)
Antioxidant approaches for the treatment of Alzheimer’s disease (2010) (117)
Mitochondrial failures in Alzheimer's disease (2004) (117)
Cyclin' toward dementia (2000) (117)
Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease (2009) (117)
Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition (2014) (116)
Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons (2010) (115)
Current approaches in the treatment of Alzheimer's disease. (2008) (114)
Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4‐hydroxy‐2‐nonenal (2000) (114)
Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. (2012) (112)
All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease (2009) (111)
DLP1‐dependent mitochondrial fragmentation mediates 1‐methyl‐4‐phenylpyridinium toxicity in neurons: implications for Parkinson’s disease (2011) (111)
Leptin inhibits glycogen synthase kinase-3β to prevent tau phosphorylation in neuronal cells (2009) (109)
Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. (2005) (108)
The role of cell cycle‐mediated events in Alzheimer's disease (1999) (107)
Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance (2014) (106)
Hydroxynonenal, toxic carbonyls, and Alzheimer disease. (2003) (106)
Carnosine: a versatile antioxidant and antiglycating agent. (2005) (106)
Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. (2002) (105)
Increased plasma leptin/fat ratio in patients with chronic renal failure: a cause of malnutrition? (1997) (105)
The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons (2012) (104)
A suicide note from Alzheimer disease neurons? (1998) (102)
Oxidative Stress, Antioxidants, and Alzheimer Disease (2000) (101)
Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. (2004) (100)
Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease (2003) (100)
The neuroprotective activities of melatonin against the Alzheimer β‐protein are not mediated by melatonin membrane receptors (2002) (99)
Signal transduction cascades associated with oxidative stress in Alzheimer's disease. (2007) (98)
Amyloid beta: the alternate hypothesis. (2006) (98)
Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. (2002) (97)
Activation of oncogenic pathways in degenerating neurons in Alzheimer disease (2000) (97)
Estimation of body composition from bioelectrical impedance of body segments: Comparison with dual-energy X-ray absorptiometry (1993) (97)
Mechanisms by which metals promote events connected to neurodegenerative diseases (2001) (96)
Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease. (2013) (96)
Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease (1996) (95)
Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli (1999) (94)
The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders (2002) (94)
Amyloid‐β‐induced toxicity of primary neurons is dependent upon differentiation‐associated increases in tau and cyclin‐dependent kinase 5 expression (2003) (93)
Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease (2010) (93)
Increased p27, an essential component of cell cycle control, in Alzheimer's disease (2003) (93)
Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease (2007) (93)
Vascular abnormalities: the insidious pathogenesis of Alzheimer’s disease☆ (2000) (93)
The cell cycle in Alzheimer disease: A unique target for neuropharmacology (2005) (93)
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice (2003) (92)
Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease (2010) (92)
Nanoparticle and iron chelators as a potential novel Alzheimer therapy. (2010) (91)
NMR studies of zinc, copper, and iron binding to histidine, the principal metal ion complexing site of amyloid-beta peptide. (2010) (91)
Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease (2004) (91)
A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer's disease. (2009) (90)
The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery. (2012) (90)
Lipoperoxidation Is Selectively Involved in Progressive Supranuclear Palsy (2000) (90)
The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. (2009) (90)
Whole body and regional body composition in patients with chronic renal failure. (1996) (89)
Faculty Opinions recommendation of Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. (2010) (89)
Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass (2014) (89)
Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. (2004) (89)
The integrin effector PINCH regulates JNK activity and epithelial migration in concert with Ras suppressor 1 (2004) (88)
Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease (1995) (86)
Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. (2002) (86)
The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease (2002) (85)
Phosphorylated tau: toxic, protective, or none of the above. (2008) (85)
Bone mass in ankylosing spondylitis. (1986) (85)
Apoptosis in Alzheimer disease: a mathematical improbability. (2006) (85)
Dysregulation of the Hypothalamic-Pituitary-Gonadal Axis with Menopause and Andropause Promotes Neurodegenerative Senescence (2005) (83)
Apoptosis and Alzheimer's Disease (1998) (83)
Oxidative damage in the olfactory system in Alzheimer's disease (2003) (83)
Transgenic Mouse Models of Alzheimer’s Disease: Behavioral Testing and Considerations (2009) (83)
Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology. (1997) (83)
Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies (2002) (82)
Pathological implications of cell cycle re-entry in Alzheimer disease (2010) (82)
Oxidative stress in Alzheimers disease (2000) (82)
Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients (2004) (82)
Increased permeability of blood–brain barrier on the hippocampus of a murine model of senescence (2007) (81)
Amyloid-β42 Interacts Mainly with Insoluble Prion Protein in the Alzheimer Brain* (2011) (81)
Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and β-amyloid in neurons. (2011) (81)
Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. (2002) (81)
Oxidative Damage to Nucleic Acids in Human Prion Disease (2002) (81)
Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease (2010) (81)
c‐Jun phosphorylation in Alzheimer disease (2007) (80)
Activation of the extracellular signal‐regulated kinase pathway contributes to the behavioral deficit of fragile x‐syndrome (2012) (79)
Dysregulated LRRK2 Signaling in Response to Endoplasmic Reticulum Stress Leads to Dopaminergic Neuron Degeneration in C. elegans (2011) (79)
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease (2009) (79)
Prion Protein Glycosylation Is Sensitive to Redox Change* (1999) (78)
Physiological regulation of tau phosphorylation during hibernation (2008) (77)
Apoptosis and Alzheimer's disease [5] (1998) (77)
Role of high mobility group protein-1 (HMG1) in amyloid-β homeostasis (2003) (75)
Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. (2008) (75)
Involvement of maillard reactions in Alzheimer disease (2009) (75)
Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-β peptide (2009) (75)
Cell cycle deregulation in the neurons of Alzheimer's disease. (2011) (74)
Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease (2009) (73)
Biomarkers in Alzheimer's disease: past, present and future. (2010) (73)
Overexpression of GRK2 in alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions (2006) (73)
Telomeres and telomerase in Alzheimer’s disease: Epiphenomena or a new focus for therapeutic strategy? (2006) (73)
The gonadotropin connection in Alzheimer’s disease (2005) (73)
Clinical benefit and preservation of flavonols in dark chocolate manufacturing. (2008) (72)
Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide (2007) (72)
Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy (1992) (72)
Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? (2002) (71)
Early AGEing and Alzheimer's (1995) (71)
Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response. (2002) (71)
LRRK2 protein is a component of lewy bodies (2006) (71)
Rolling blackout, a newly identified PIP2-DAG pathway lipase required for Drosophila phototransduction (2004) (69)
Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. (2007) (69)
Mitochondrial Dynamics in Alzheimer’s Disease (2010) (69)
Induction of HO-1 and NOS in Doppel-Expressing Mice Devoid of PrP: Implications for Doppel Function (2001) (68)
Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia (2009) (68)
LIM Domains Target Actin Regulators Paxillin and Zyxin to Sites of Stress Fiber Strain (2013) (67)
Measurement of body composition in chronic renal failure: comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry. (1996) (67)
Prevention and treatment of Alzheimer disease and aging: antioxidants. (2007) (67)
Accelerated α-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells (2004) (67)
Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s disease (2010) (67)
Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways. (2003) (67)
Cerebrovascular muscle atrophy is a feature of Alzheimer's disease (1998) (67)
Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene (2009) (67)
Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death (2011) (66)
Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. (2007) (66)
Causes versus effects: the increasing complexities of Alzheimer’s disease pathogenesis (2010) (66)
Trichosanthin induced apoptosis in HL-60 cells via mitochondrial and endoplasmic reticulum stress signaling pathways. (2007) (66)
Arson: Tracking the Culprit in Alzheimer's Disease (2000) (66)
Antioxidant protection and neurodegenerative disease: The role of amyloid-β and tau (2006) (66)
Neurofilamentopathy in Neurodegenerative Diseases (2011) (65)
Mechanisms and Consequences of Ebolavirus-Induced Lymphocyte Apoptosis (2009) (65)
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer’s disease (2008) (65)
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease (2005) (65)
Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases. (2012) (65)
Oxidative posttranslational modifications in Alzheimer disease (1996) (64)
Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease (2000) (64)
Ectopic expression of phospho‐Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor‐β pathway? (2006) (62)
The Autistic Phenotype Exhibits a Remarkably Localized Modification of Brain Protein by Products of Free Radical-Induced Lipid Oxidation (2008) (62)
Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease (2008) (62)
Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP‐1‐associated regulator of cyclin B, in Alzheimer's disease (2004) (62)
Redox metals and oxidative abnormalities in human prion diseases (2005) (61)
Early Induction of Oxidative Stress in Mouse Model of Alzheimer Disease with Reduced Mitochondrial Superoxide Dismutase Activity (2012) (61)
Down‐regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause‐associated cognitive deficits (2010) (61)
JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease (2003) (61)
LRRK2 in Parkinson's disease and dementia with Lewy bodies (2006) (60)
Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease (2007) (60)
Causes and consequences of oxidative stress in Alzheimer's disease. (2002) (60)
Walking Toward a Convergence in Aging Research (2009) (59)
BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease (2007) (59)
Distribution, levels, and activation of MEK1 in Alzheimer's disease (2003) (58)
The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development. (2007) (58)
Measurement of total body water by bioelectrical impedance in chronic renal failure. (1996) (58)
Lithium Treatment Decreases Activities of Tau Kinases in a Murine Model of Senescence (2008) (58)
A phantom for quantitative ultrasound of trabecular bone. (1994) (58)
Nuclear and mitochondrial DNA oxidation in Alzheimer's disease (2012) (58)
Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease. (2010) (57)
Faculty Opinions recommendation of Autophagy protects neuron from Abeta-induced cytotoxicity. (2010) (57)
Neuroprotective effect of cocoa flavonids on in vitro oxidative stress (2009) (57)
A Metabolic Basis for Alzheimer Disease (2003) (57)
Quantitative solubilization and analysis of insoluble paired helical filaments from alzheimer disease (1996) (57)
Homocysteine and Alzheimer's disease: a modifiable risk? (2004) (57)
Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer’s disease pathogenesis (2004) (57)
Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress (1995) (56)
Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer’s disease (2004) (56)
Mitochondrial Preconditioning: A Potential Neuroprotective Strategy (2010) (55)
Signaling effect of amyloid-β42 on the processing of AβPP (2010) (55)
The role of metabotropic glutamate receptors in Alzheimer's disease. (2004) (54)
Perspectives on the Amyloid-β Cascade Hypothesis (2004) (53)
Amyloid‐β in Alzheimer's disease: the horse or the cart? Pathogenic or protective? (2005) (53)
Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. (2002) (52)
Effects of orthotopic liver transplantation on body composition. (2008) (52)
Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes (2000) (52)
Hippocampal neurogenesis and PSA-NCAM expression following exposure to 56Fe particles mimics that seen during aging in rats (2005) (51)
Apoptotic promoters and inhibitors in Alzheimer's disease: Who wins out? (2003) (51)
Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer’s brain (2013) (51)
Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism (2003) (50)
Redox active iron accumulation in aceruloplasminemia (2008) (50)
Predicting the failure of amyloid-β vaccine (2002) (50)
Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. (2003) (50)
Antigen–antibody dissociation in Alzheimer disease: a novel approach to diagnosis (2008) (49)
Neuroprotective properties of Bcl‐w in Alzheimer disease (2004) (49)
Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease. (2009) (49)
α‐Synuclein facilitates the toxicity of oxidized catechol metabolites: Implications for selective neurodegeneration in Parkinson's disease (2006) (49)
Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply (2003) (49)
Reply to 'Comment on 'A systematic review of the precision and accuracy of dose measurements in photon radiotherapy using polymer and Fricke MRI gel dosimetry''. (2003) (49)
A Novel Origin for Granulovacuolar Degeneration in Aging and Alzheimer’s Disease: Parallels to Stress Granules (2011) (48)
Down‐regulation of serum gonadotropins but not estrogen replacement improves cognition in aged‐ovariectomized 3xTg AD female mice (2014) (47)
Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease. (2004) (47)
Aberrant localization of importin α1 in hippocampal neurons in Alzheimer disease (2006) (47)
Mitochondria: the missing link between preconditioning and neuroprotection. (2010) (47)
Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage. (2003) (47)
Bone ultrasonic attenuation in women: reproducibility, normal variation and comparison with photon absorptiometry. (1992) (46)
Do β-Defensins and Other Antimicrobial Peptides Play a Role in Neuroimmune Function and Neurodegeneration? (2012) (46)
Amyloid-β: a (life) preserver for the brain (2002) (45)
Compensatory responses induced by oxidative stress in Alzheimer disease. (2006) (45)
A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks. (2015) (45)
Molecular Pathogenesis of Alzheimer’s Disease: Reductionist versus Expansionist Approaches (2009) (45)
Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease. (2005) (44)
Therapeutic opportunities in Alzheimer disease: one for all or all for one? (2005) (44)
Prediction of fracture healing in the tibia by quantitative radionuclide imaging. (1987) (44)
The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau (2002) (44)
Estrogen Bows to a New Master: The Role of Gonadotropins in Alzheimer Pathogenesis (2005) (43)
Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. (2008) (43)
Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis (2011) (43)
Premature centromere division of the X chromosome in neurons in Alzheimer’s disease (2008) (43)
Alzheimer's disease and the cell cycle. (2004) (42)
The Contribution of Luteinizing Hormone to Alzheimer Disease Pathogenesis (2007) (42)
Novel therapeutics for Alzheimer's disease: an update. (2010) (42)
Bone mass in nodal primary generalised osteoarthrosis. (1984) (42)
Therapeutic options in Alzheimer’s disease (2006) (42)
Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. (2004) (42)
Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. (2003) (42)
Chronological primacy of oxidative stress in Alzheimer disease (2005) (42)
Chitin-like polysaccharides in Alzheimer's disease brains. (2005) (41)
Regional bone mineral density after orthotopic liver transplantation. (1999) (41)
Primary generalized osteoarthritis and bone mass. (1993) (41)
Malignant glioma progression and nitric oxide (2006) (41)
Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease (2008) (41)
Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. (2007) (41)
Cell Cycle Re-Entry and Mitochondrial Defects in Myc-Mediated Hypertrophic Cardiomyopathy and Heart Failure (2009) (40)
Bone loss in rheumatoid arthritis and primary generalized osteoarthrosis: effects of corticosteroids, suppressive antirheumatic drugs and calcium supplements. (1986) (40)
Risk factors for asthma deaths: a population‐based, case‐control study (1999) (40)
Oxidative stress and iron imbalance in Alzheimer disease: how rust became the fuss! (2006) (40)
Activation of Akt by lithium: Pro-survival pathways in aging (2009) (40)
Heme catabolism and heme oxygenase in neurodegenerative disease. (2004) (39)
Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer's disease (2011) (39)
Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? (2007) (39)
P38 Activation Mediates Amyloid-β Cytotoxicity (2005) (39)
Cholesterol homeostasis markers are localized to mouse hippocampal pyramidal and granule layers (2010) (38)
Retinoic acid isomers protect hippocampal neurons from amyloid-β induced neurodegeneration (2009) (38)
Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. (2007) (38)
Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease (2009) (37)
Neuroprotective effects of caffeine against complex I inhibition–induced apoptosis are mediated by inhibition of the Atm/p53/E2F‐1 path in cerebellar granule neurons (2007) (37)
A Novel Endogenous Indole Protects Rodent Mitochondria and Extends Rotifer Lifespan (2010) (37)
A mechanical-biochemical feedback loop regulates remodeling in the actin cytoskeleton (2014) (37)
Reduced homocysteine-thiolactonase activity in Alzheimer's disease. (2010) (37)
Getting the iron out: phlebotomy for Alzheimer's disease? (2009) (37)
Regulation of glycogen synthase kinase‐3β by products of lipid peroxidation in human neuroblastoma cells (2004) (37)
Steroidogenic Acute Regulatory Protein (StAR): Evidence of Gonadotropin-Induced Steroidogenesis in Alzheimer Disease (2006) (37)
Variation in lumbar spine and femoral neck bone mineral measured by dual energy X-ray absorption: a study of 329 normal women. (1993) (36)
Differential Regulation of Glutamate Receptors in Alzheimer’s Disease (2002) (36)
A systematic review of the precision and accuracy of dose measurements in photon radiotherapy using polymer and Fricke MRI gel dosimetry. (2003) (36)
Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease. (2009) (36)
Insulin signaling, diabetes mellitus and risk of Alzheimer disease. (2005) (36)
The LIM Protein Zyxin Binds CARP-1 and Promotes Apoptosis. (2010) (35)
Measurement of total body water and urea kinetic modelling in peritoneal dialysis. (1997) (35)
Emerging evidence for the neuroprotective role of α-synuclein (2006) (35)
MAPKs are differentially modulated in arctic ground squirrels during hibernation (2005) (35)
Role of Oxidative Stress in Frontotemporal Dementia (1999) (35)
What are the facts and artifacts of the pathogenensis and etiology of Alzheimer disease? (1998) (35)
Dissociated amyloid-β antibody levels as a serum biomarker for the progression of Alzheimer’s disease: A population-based study (2010) (34)
The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease. (2004) (34)
Leucine-Rich Repeat Kinase 2 Colocalizes with α-Synuclein in Parkinson’s Disease, but Not Tau-Containing Deposits in Tauopathies (2008) (34)
Hypoperfusion, Mitochondria Failure, Oxidative Stress, and Alzheimer Disease (2003) (34)
The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention. (2011) (34)
The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival (2009) (34)
The Cell Cycle Regulator Phosphorylated Retinoblastoma Protein Is Associated With Tau Pathology in Several Tauopathies (2011) (34)
Book Review: Is Alzheimer’s Disease a Mitochondrial Disorder? (2002) (34)
Autophagy in Alzheimer’s disease (2010) (33)
Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease. (2004) (33)
Oxidative damage and Alzheimer's disease: are antioxidant therapies useful? (2005) (33)
Clusterin up-regulation following sub-lethal oxidative stress and lipid peroxidation in human neuroblastoma cells (2006) (32)
Mitogen‐ and stress‐activated protein kinase 1: Convergence of the ERK and p38 pathways in Alzheimer's disease (2005) (32)
The role of novel chitin-like polysaccharides in Alzheimer disease (2007) (32)
Frontiers in Alzheimer’s disease therapeutics (2011) (32)
Gender Differences in Alzheimer Disease: The Role of Luteinizing Hormone in Disease Pathogenesis (2005) (32)
Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. (2012) (31)
Neurons in Alzheimer disease emerge from senescence (2001) (31)
Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment. (2010) (31)
Early contribution of oxidative glycation in Alzheimer disease (1996) (31)
Tau phosphorylation and assembly. (2004) (31)
Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease. (2006) (30)
Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment (2013) (30)
Melatonin reduces interleukin secretion in amyloid-β stressed mouse brain slices (2001) (30)
Total body neutron activation analysis of calcium: calibration and normalisation. (1982) (30)
Striation is the characteristic neuritic abnormality in Alzheimer disease (1998) (30)
Amyloid‐β: A vascular sealant that protects against hemorrhage? (2002) (29)
Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming! (2012) (29)
Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress (2009) (28)
New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotection. (2011) (28)
Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection. (2004) (28)
The X-chromosome instability phenotype in Alzheimer's disease: a clinical sign of accelerating aging? (2009) (28)
PKC inhibition is involved in trichosanthin-induced apoptosis in human chronic myeloid leukemia cell line K562. (2007) (28)
Will antioxidants fulfill their expectations for the treatment of Alzheimer disease? (2000) (28)
Cerebral Hemorrhage and Amyloid-β (2003) (27)
Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease? (2004) (27)
Assembly in vitro of tau protein and its implications in Alzheimer's disease. (2004) (27)
Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers (2005) (26)
Microbial origin of glutamate, hibernation and tissue trauma: an in vivo microdialysis study (2002) (26)
Neuroinflammatory Responses in the Alzheimer's Disease Brain Promote the Oxidative Post‐translational Modification of Amyloid Deposits (2002) (26)
Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective? (2005) (26)
Alzheimer's disease and oxidative stress: The old problem remains unsolved (2005) (26)
α1-Trypsin Immunoreactivity in Alzheimer Disease (1993) (26)
Mitochondrial abnormalities and oxidative imbalance in neurodegenerative disease. (2002) (25)
Neuronal cell cycle re-entry markers are altered in the senescence accelerated mouse P8 (SAMP8). (2012) (25)
Prion disease and Alzheimer's disease: pathogenic overlap. (2004) (24)
Influence of changes in peritoneal fluid on body-composition measurements by dual-energy X-ray absorptiometry in patients receiving continuous ambulatory peritoneal dialysis. (1996) (24)
Bone mass in osteoarthritis. (1992) (24)
Four-component model of body composition in chronic renal failure comprising dual-energy X-ray absorptiometry and measurement of total body water by deuterium oxide dilution. (1996) (24)
Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies. (2008) (24)
Mathematical modeling of microtubule dynamics: Insights into physiology and disease (2010) (24)
Indices of Metabolic Dysfunction and Oxidative Stress (2007) (24)
Predicting the failure of amyloid-beta vaccine. (2002) (24)
Metals and oxidative homeostasis in Alzheimer's disease (2002) (24)
Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity. (2008) (24)
Call for Elan to publish Alzheimer's trial details (2002) (23)
Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation (1994) (23)
Asking the Right Questions (1999) (23)
P38 activation mediates amyloid-beta cytotoxicity. (2005) (23)
Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: synthesis, neuronal cell culture investigations, and CDK5 docking studies. (2011) (23)
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease. (2010) (23)
Altered cell‐matrix associated ADAM proteins in Alzheimer disease (2000) (23)
Development of apparatus to measure calcium changes in the forearm and spine by neutron activation analysis using californium-252. (1979) (23)
5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology. (2019) (23)
Possible involvement of Wiskott–Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer's disease (2003) (22)
Amyloid-β: redox-metal chelator and antioxidant (2002) (22)
Is the time dimension of the cell cycle re-entry in AD regulated by centromere cohesion dynamics? (2008) (22)
Will Preventing Protein Aggregates Live Up to Its Promise as Prophylaxis Against Neurodegenerative Diseases? (2003) (22)
Modification of amyloid-β1-42 fibril structure by methionine-35 oxidation. (2013) (22)
The key role of oxidative stress in alzheimer's disease (2007) (22)
Accumulation of intraneuronal amyloid-β is common in normal brain. (2014) (21)
Alzheimer's disease: an intracellular movement disorder? (2005) (21)
The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease (2006) (21)
Tipping the apoptotic balance in Alzheimer's disease (2007) (21)
Early induction of c-Myc is associated with neuronal cell death (2011) (21)
Lateral communication between stress fiber sarcomeres facilitates a local remodeling response. (2012) (21)
Alzheimer's disease: A century of scientific and clinical research (2006) (21)
Widespread distribution of reticulon‐3 in various neurodegenerative diseases (2010) (20)
Characterization of the F198S prion protein mutation: enhanced glycosylation and defective refolding. (2005) (20)
Iron: A Pathological Mediator of Alzheimer Disease? (2009) (20)
Soluble amyloid beta-protein is increased in frontotemporal dementia with tau gene mutations. (2004) (20)
The actin regulator zyxin reinforces airway smooth muscle and accumulates in airways of fatal asthmatics (2017) (20)
Total and peripheral bone mass in patients with psoriatic arthritis and rheumatoid arthritis (1986) (20)
The effect of arteriovenous fistulae in haemodialysis patients on whole body and segmental bioelectrical impedance. (1997) (20)
Risk factors for loss of lean body mass after liver transplantation. (1998) (20)
Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation (2008) (20)
The essence of chocolate: a rich, dark, and well-kept secret. (2009) (20)
Mislocalization of CDK11/PITSLRE, a regulator of the G2/M phase of the cell cycle, in Alzheimer disease (2011) (19)
Staying connected: synapses in Alzheimer disease. (2004) (18)
Comparison of conventional spin-echo and fast spin-echo magnetic resonance imaging in the canine brain. (2006) (18)
Chapter 5 - Development of iron chelator-nanoparticle conjugates as potential therapeutic agents for Alzheimer disease. (2009) (18)
Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease (2009) (18)
Protein Modification by Dicarbonyl Molecular Species in Neurodegenerative Diseases (2011) (17)
Presenilin 1 overexpressions in Chinese hamster ovary (CHO) cells decreases the phosphorylation of retinoblastoma protein: relevance for neurodegeneration (2002) (17)
Amyloid-β Vaccination: Testing the Amyloid Hypothesis? : Heads We Win, Tails You Lose! (2006) (17)
Premature centromere division of metaphase chromosomes in peripheral blood lymphocytes of Alzheimer's disease patients: relation to gender and age. (2010) (17)
Alzheimer's Disease: Advances for a New Century (2012) (17)
Tau modifiers as therapeutic targets for Alzheimer's disease. (2005) (17)
Normal levels of total body sodium and chlorine by neutron activation analysis. (1983) (17)
MITOCHONDRIA ABNORMALITIES MARK VULNERABLE NEURONS IN ALZHEIMER DISEASE (1999) (17)
Induction of NADPH cytochrome P450 reductase by the Alzheimer β‐protein. Amyloid as a ‘foreign body’ (2001) (17)
Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream. (2006) (16)
Mitotic Neurons: A Dogma Succumbs (1999) (16)
Histochemical and Immunocytochemical Approaches to the Study of Oxidative Stress (2000) (16)
Nanowired drug delivery of antioxidant compound H-290/51 enhances neuroprotection in hyperthermia-induced neurotoxicity. (2012) (16)
Neuroprotective effects of SB-415286 on hydrogen peroxide-induced cell death in B65 rat neuroblastoma cells and neurons (2008) (16)
Amyloid-beta: a vascular sealant that protects against hemorrhage? (2002) (16)
Is amyloid β‐protein glycated in Alzheimer's disease? (1997) (16)
Perspectives on the amyloid-beta cascade hypothesis. (2004) (15)
Segmental bioelectrical impedance in patients with chronic renal failure. (1996) (15)
Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress. (2012) (15)
Ascorbate distribution during hibernation is independent of ascorbate redox state. (2004) (15)
Therapeutic potential of c-Myc inhibition in the treatment of hypertrophic cardiomyopathy (2011) (15)
Therapeutic potential of oxidant mechanisms in Alzheimer’s disease (2004) (15)
Dimension-Splitting for Simplifying Diffusion in Lattice-Gas Models (2001) (14)
Mitochondrial Dynamics in Alzheimer's Disease Opportunities for Future Treatment Strategies (2010) (14)
The essential role of ERK in 4‐oxo‐2‐nonenal‐mediated cytotoxicity in SH‐SY5Y human neuroblastoma cells (2009) (14)
Treating the lesions, not the disease. (2007) (14)
Estrogen replacement and risk of Alzheimer disease. (2003) (14)
Increased Expression of p130 in Alzheimer Disease (2007) (14)
Chronic Leptin Supplementation Ameliorates Pathology and Improves Cognitive Performance in a Transgenic Mouse Model of Alzheimer's Disease. (2009) (13)
Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress (2007) (13)
Evaluation of the dosimetric performance of BANG3® polymer gel (2005) (13)
Ferric cycle activity and Alzheimer disease. (2005) (13)
Divalent metal transporter, iron, and Parkinson's disease: A pathological relationship (2010) (13)
The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target. (2006) (13)
The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimers Disease (2002) (13)
Dual photon absorptiometry of the spine with a low activity source of gadolinium 153. (1983) (13)
Assessment of the Evolutionary Origin and Possibility of CRISPR-Cas (CASS) Interference Pathway in Vibrio cholerae O395 (2009) (13)
VULNERABLE NEURONS IN ALZHEIMER DISEASE ACCUMULATE MITOCHONDRIAL DNA WITH THE COMMON 5KB DELETION (1998) (13)
Assessment of the evolutionary origin and possibility of CRISPR-Cas (CASS) mediated RNA interference pathway in Vibrio cholerae O395. (2009) (13)
Changes in total body calcium following surgery for primary hyperparathyroidism. (1986) (13)
Emerging evidence for the neuroprotective role of alpha-synuclein. (2006) (13)
Targeting Gonadotropins: An Alternative Option for Alzheimer Disease Treatment (2006) (13)
DNA damage induces cdk2 protein levels and histone H2B phosphorylation in SH-SY5Y neuroblastoma cells. (2005) (12)
Amyloid-beta: a (life) preserver for the brain. (2002) (12)
Enhanced Phosphorylation of Bax and Its Translocation into Mitochondria in the Brains of Individuals Affiliated with Alzheimer’s Disease (2017) (12)
Body composition analysis in liver cirrhosis. The measurement of body fat by dual energy X-ray absorptiometry in comparison to skinfold anthropometry, bioelectrical impedance and total body potassium. (1993) (12)
Apparatus for the measurement of total body nitrogen using prompt neutron activation analysis with californium-252. (1988) (12)
The "Down's" side of mitochondria. (2002) (12)
Mitochondrial Drugs for Alzheimer Disease (2009) (12)
Menopause, estrogen, and gonadotropins in Alzheimer's disease. (2008) (12)
Effect of Calmodulin and Protein Kinase C Inhibitors on Globally Ischemic Rat Hearts (1992) (12)
A four-compartment model to determine body composition in liver cirrhosis. (1993) (12)
Bone Mass in Corticosteroid Treated Patients with Rheumatoid Arthritis, Asthma and Polymyalgia Rheumatica (1985) (11)
Oxidant and antioxidant responses in Alzheimer disease (2001) (11)
Neural circuit involved in idiopathic infantile nystagmus syndrome based on FMRI. (2011) (11)
The assessment of postmenopausal osteoporosis by total body neutron activation analysis. (1983) (11)
Comparison between 153Gd and 241Am, 137Cs for dual-photon absorptiometry of the spine. (1983) (11)
A second look into the oxidant mechanisms in Alzheimer's disease. (2005) (11)
The Application of Microarray Technology to Neuropathology: Cutting Edge Tool With Clinical Diagnostics Potential or Too Much Information? (2006) (11)
RNA Oxidation in Alzheimer and Parkinson Diseases (1999) (11)
Changes in total body calcium after renal transplantation: effect of low-dose steroid regime. (1985) (10)
In vivo precision of total body calcium and sodium measurements by neutron activation analysis. (1987) (10)
A New Model of Oxidative Stress in Rat Pups (2008) (10)
Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia (2007) (10)
Measurement of hand bone mineral content using single-photon absorptiometry. (1987) (10)
CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease (2010) (10)
Ill‐fated amyloid‐β vaccine (2002) (10)
Heme Deficiency in Alzheimer's Disease: A Possible Connection to Porphyria (2006) (10)
Melatonin exhibits antioxidant properties in a mouse brain slice model of excitotoxicity. (2002) (10)
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets (2009) (9)
Modeling cholesterol metabolism by gene expression profiling in the hippocampus. (2011) (9)
Antigonadotropins: a novel strategy to halt Alzheimer's disease progression. (2006) (9)
Age related changes in body composition. (1998) (9)
The Role of Oxidative Damage to Nucleic Acids in the Pathogenesis of Neurological Disease (2007) (9)
Presenilin mutation: a deadly first hit in Alzheimer disease. A commentary on "aging sensitizes towards ROS formation and lipid peroxidation in PS1M146L transgenic mice". (2006) (9)
Direct and Indirect Roles of Cyclin-dependent Kinase 5 as an Upstream Regulator in the c-Jun NH 2-Terminal Kinase Cascade : Relevance to Neurotoxic Insults in Alzheimer ’ s Disease (2009) (9)
Open peer commentary Copernicus revisited: amyloid beta in Alzheimer's disease (2001) (8)
Long-Term Effect of Dialysate Calcium and 1α-Hydroxycholecalciferol on Bone Calcium Content in Haemodialysis Patients as Measured by Neutron Activation Analysis of the Forearm (1981) (8)
Heme-a, the heme prosthetic group of cytochrome c oxidase, is increased in Alzheimer's disease (2009) (8)
Cellular prion protein is essential for oligomeric amyloid- b -induced neuronal cell death (2012) (8)
Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain. (2009) (8)
Activation of P38 kinase links π phosphorylation, oxidative stress and cell cycle-related events in Alzheimer disease (2000) (8)
A further assessment of an electromagnetic method to measure body composition. (1995) (8)
Therapeutic potential of oxidative stress reduction in Alzheimer's disease (2006) (7)
When hypotheses dominate (2004) (7)
A diet at amyloid beta? (2001) (7)
A simple model for pollen-parent fecundity distributions in bee-pollinated forage legume polycrosses (2015) (7)
Signal Transduction in Alzheimer’s Disease (2002) (7)
The comparison of neutron activation analysis and photon absorptiometry at the same part-body site. (1981) (7)
An investigation of an electromagnetic method for the measurement of body composition. (1994) (7)
Paraffin-embedded tissue (PET) blot method: Application to Alzheimer disease (2010) (7)
The role of E2F1 in the development of hypertrophic cardiomyopathy. (2011) (7)
Altered redox balance in disease: Can we change the new equilibria? (2009) (7)
The optical properties of skin tumours measured during superficial photodynamic therapy (1994) (7)
Large-Scale Functional Annotation and Expanded Implementations of the P{wHy} Hybrid Transposon in the Drosophila melanogaster Genome (2009) (7)
Ciprofloxacin Does Not Exert Nephrotoxicity in Rats (2005) (7)
Cell cycle aberrations in Alzheimer’s disease: a novel therapeutic opportunity (2009) (7)
Social Work in a Changing Scotland (2018) (7)
Redox active iron at the center of oxidative stress in Alzheimer disease (2005) (7)
Effect of the herbicide 4-CPA on human erythrocyte antioxidant enzymes in vitro (2001) (7)
Mechanisms of DNA Damage and Repair in Alzheimer Disease (2006) (6)
Amyotrophic lateral sclerosis: a novel hypothesis involving a gained 'loss of function' in the JNK/SAPK pathway (2003) (6)
Standing up to complexity: researching moral panics in social work (2016) (6)
Apoptotic and Oxidative Indicators in Alzheimer’s Disease (2002) (6)
Scale and Hierarchy Theory (2002) (6)
Heads We Win, Tails You Lose! (2006) (6)
S4-02-01 Alzheimer disease: the two hit hypothesis (2004) (6)
P3-296 Luteinizing hormone mediates Alzheimer-type changes in neurons (2006) (6)
Neurogenesis in Human Hippocampus: Implications for Alzheimer Disease Pathogenesis (2006) (6)
The Coming Out Process (2017) (5)
Putative Gonadotropin-Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data. (2018) (5)
MDA and GSH levels in newly diagnosed Alzheimer's disease patients: A population-based study (2010) (5)
Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression". (2006) (5)
Elevation of-Amyloid 1-42 Autoantibodies in the Blood of Amnestic Patients With Mild Cognitive Impairment (2010) (5)
Dangers of the amyloid-β vaccination (2002) (5)
Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease. (2010) (5)
Neurofibrillary Tangle Formation as a Protective Response to Oxidative Stress in Alzheimer’s Disease (2009) (5)
Research report Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease (1998) (5)
The crossover correction in dual photon absorptiometry with 153Gd. (1982) (5)
Neuroinflammatory Environments Promote Amyloid-ß Deposition and Posttranslational Modification (2003) (5)
Plasma Exchange in Late Gestosis (1981) (5)
The pathology of Alzheimer disease elicits an in vivo immunological response (2007) (5)
Quantitative Languages for Complex Systems Applied to Biological Structure (2000) (5)
Neuroendocrinology‐based therapy for Alzheimer's disease (2012) (5)
Oncogenic parallels in Alzheimer disease (2006) (5)
Ameliorating slice gaps in multislice magnetic resonance images: an interpolation scheme (2014) (4)
Absence of Cellular Stress in Brain Following Hypoxia Induced by Arousal from Hibernation in Arctic Ground Squirrels (2005) (4)
The Role of Oxidative Stress in the Pathological Sequelae of Alzheimer Disease (1998) (4)
Brain Lesions among Orally Fed and Gastrostomy-Fed Dysphagic Preterm Infants: Can Routine Qualitative or Volumetric Quantitative Magnetic Resonance Imaging Predict Feeding Outcomes? (2017) (4)
Inelastic scattering of pulsed 14.4 MeV neutrons as a function of depth in tissue and the half-life for radiative capture. (1991) (4)
Multi-frequency bio-electrical impedance: precision in normal children. (1998) (4)
Youth Work and Faith: debates, delights and dilemmas (2015) (4)
Commentary: “Ceramide and cholesterol: Possible connections between normal aging of the brain and Alzheimer’s disease. Just hypotheses or molecular pathways to be identified?” By Claudio Costantini, Rekha M.K. Kolasani, and Luigi Puglielli (2005) (4)
Alzheimer’s Disease: An Overview (2009) (4)
Natural oxidant balance in Parkinson disease. (2009) (4)
OXIDATION OF NUCLEIC ACIDS IN NEURONS PRECEDES AMYLOID $BT DEPOSITION IN DOWN SYNDROME (1999) (4)
Antibodies to Potato Virus Y Bind the Amyloid β Peptide (2008) (4)
Is intraneuronal amyloid beta-peptide accumulation the trigger of Alzheimer's disease pathophysiology? (2004) (4)
Moral Panics, Jimmy Savile and Social Work: a 21st century morality tale (2014) (4)
A portable system for measuring bone mineral density in the pre-term neonatal forearm. (1996) (4)
Oxidative Stress Mechanisms and Potential Therapeutic Modalities in Alzheimer Disease (2004) (4)
Therapeutic options in Alzheimers disease (2006) (4)
Oxidative Stress in Alzheimer’s Disease: A Critical Appraisal of the Causes and the Consequences (2011) (4)
Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease. (2011) (4)
What went wrong at Captiva and what should happen next (1999) (4)
The measurement of total body fat by dual energy X-ray absorptiometry: comparison with skinfold anthropometry, bioelectrical impedance and total body potassium. (1993) (4)
Nuclear microscopy of diffuse plaques in the brains of transgenic mice (2005) (4)
Erratum: Autophagocytosis of mitochondria is prominent in Alzheimer disease (Journal of Neuropathology and Experimental Neurology (2007) 66, (525-532)) (2007) (4)
Nanoparticles for the Treatment of Alzheimer's Disease: Theoretical Rationale, Present Status and Future Perspectives (2007) (4)
Treatment advances in Alzheimer's disease based on the oxidative stress model (2009) (4)
Two Hits and You’re Out? A Novel Mechanistic Hypothesis of Alzheimer Disease (2008) (4)
Evidence for Oxidative Damage in the Autistic Brain (2009) (4)
Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose! (2006) (4)
Sources contributing to the initiation and propagation of oxidative stress in Alzheimer disease (2003) (4)
Prospects for antioxidant therapy in mild cognitive impairment and alzheimer's disease (2007) (4)
Ubiquitin/proteasome system in mitotic and mitotic-like regulation during brain development and pathology. (2010) (3)
Cerebrotendinous xanthomatosis: a critical update (2008) (3)
Amyloids, Aggregates and Neuronal Inclusions: Good or Bad News for Neurons? (2003) (3)
Methods in Molecular Medicine, Vol. 32 Alzheimer's Disease: Methods and Protocols (2000) (3)
Neurodegenerative Diseases: Mechanisms and Therapies (2006) (3)
Mechanisms Involved in Gender Differences in Alzheimer's Disease: The Role of Leuteinizing and Follicle Stimulating Hormones (2004) (3)
Feedback on a feedback loop: the hypothalamic-pituitary-gonadal axis. (2005) (3)
Erratum: Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease (Journal of Neurochemistry 85 (1101-1108)) (2003) (3)
Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy (2010) (3)
CorrigendumCorrigendum to “Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture investigations, and CDK5 docking studies” [Bioorg. Med. Chem. Lett. 11 (2001) 3165–3168] (2011) (3)
A novel approach for predicting the evolutionary time of acquisition of foreign genes by bacteria: Application of codon usage analyses (2009) (3)
Biochemistry of neurodegeneration [2] (multiple letters) (2001) (3)
Alzheimer Disease: Oxidative Stress and Compensatory Responses (2009) (3)
Alzheimer Research Forum Live Discussion: sports concussions, dementia, and ApoE genotyping: what can scientists tell the public? What's up for research? (2009) (3)
4-HYDROXYNONENAL-DERIVED LIPID PF.ROXIDATION END PRODUCTS ARE INCREASED IN ALZHEIMER DISEASE (1997) (3)
Research report Accelerated a-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells (2004) (3)
Metal-Catalyzed Redox Activity in Neurodegenerative Disease (2003) (3)
Pathology's new role: defining disease process and protective responses. (2008) (3)
Oxidative Damage and Antioxidant Responses in Alzheimer's Disease (2002) (3)
Hibernation, a Model of Neuroprotection (2001) (3)
Private Troubles or Public Issues? (2017) (2)
Potential role of iron in a Mediterranean-style diet. (2010) (2)
"Hypothesis Testing" not "Disease Modifying" in Alzheimer's Disease (2010) (2)
Ill-fated amyloid-beta vaccine. (2002) (2)
Preface. Alzheimer's disease: advances for a new century. (2013) (2)
In Situ Localization of Nonenzymatic Peroxidase‐Like Activity of Tissue‐Bound Transition Metals (2004) (2)
IRON REGULATORY PROTEINS IN ALZHEIMER DISEASE (1998) (2)
The seasonal variation of total body calcium. (1986) (2)
Measurement of spinal calcium by in vivo neutron activation analysis in osteoporosis. (1981) (2)
Short Communication Immunocytochemical Evidence That the (3-Protein Precursor Is an Integral Component of Neurofibrillary Tangles of Alzheimer's Disease (2007) (2)
Oxidative Stress in Parkinson’s Disease (2009) (2)
Lipoic Acid and N‐Acetyl Cysteine Protect Against Mitochondrial‐Related Oxidative Stress in Fibroblasts from Alzheimer Disease Patients (2007) (2)
Chapter 1 - Ischemic Tolerance in the Brain: Models and Mechanisms (2002) (2)
Down syndrome and Alzheimer disease: A "multi-hit" hypothesis based on multiple contributing factors resulting in pleotrophic consequences (2011) (2)
Antioxidant Therapies in the Prevention and Treatment of Alzheimer Disease (2005) (2)
Hydroxynonenal-Generated Crosslinking Fluorophore and Mitochondria-derived Lipoic Acid Accumulation in Alzheimer Disease Reveal a Dichotomy of Protein Turnover (2010) (2)
P3-219 Acetylation: a novel posttranslational modification in Alzheimer disease (2002) (2)
A total body phantom for use with Lunar dual-energy X-ray absorptiometers. (1998) (2)
Role of Heme Catabolism in Neurodegenerative Diseases (2002) (2)
Role of Oxidative Insult and Neuronal Survival in Alzheimer’s and Parkinson’s Diseases (2008) (2)
8 – Prion and Alzheimer Diseases: The Road to Pathogenesis is Paved with Copper (2002) (2)
Causes and consequences of oxidative stress in Alzheimers disease 1,2 1 Guest Editors: Mark A. Smit (2002) (2)
Whole-body and part-body turnover of 85Sr in Paget's disease. (1983) (2)
IMUNOHISTOCHEMICAL EVIDENCE OF OXIDATIVE STRESS IN PARKINSONʼS DISEASE (PD) (1996) (2)
Erratum: Prion protein glycosylation is sensitive to redox change (Journal of Biological Chemistry (1999) 274 (34846-34850)) (2000) (2)
P3-422: Impaired balance of mitochondrial fission and fusion in susceptible neurons of Alzheimer disease (2008) (2)
Mitochondria and Neurodegenerative Diseases (2010) (2)
RAD 21 cohesion protein shows altered levels of expression in the Swedish mutant phenotype of M17 neuroblastoma cells (2010) (2)
HIGH MOLECULAR WEIGHT NEUROFILAMENT PROTEINS (2001) (2)
Cellular Respiration and Tumor Suppressor Genes (2009) (2)
The use of a radiation sensitive CCD camera system to measure bone mineral content in the neonatal forearm: a feasibility study. (1992) (2)
Erratum: Advanced maillard reaction end products are associated with Alzheimer disease pathology (Proceedings of the National Academy of Sciences of the United States of America (June 7, 1994) 91 (5710-5714) (1995) (2)
Social Working (1995) (1)
Oxidative Stress and Neuronal Adaptation in Alzheimer Disease (2003) (1)
Abstract Meeting of the Bone and Tooth Society, Edinburgh (March, 1984)The prediction of nonunion in tibial fractures using quantitative bone scanning and fracture shift (1985) (1)
Nutrients and Food Constituents in Cognitive Decline and Neurodegenerative Disease (2013) (1)
Role of Amyloid‐β in Alzheimer's Disease (2005) (1)
Rethinking Criminal Justice in Scotland (2017) (1)
Food Antioxidants and Alzheimer’s Disease (2009) (1)
Revisiting Moral Panics (2015) (1)
What oxidative stress tells us about therapeutic targets for Alzheimer's disease (2000) (1)
Ethics for Scottish social work (2018) (1)
Learning democracy ; a case study of learning democracy in a peri- urban community development project. (2003) (1)
P4-354 Luteinizing hormone: A unifying hypothesis for Alzheimer disease etiology, pathogenesis and treatment (2006) (1)
PO13-357 THE PRIMARY PATHOGENETIC ROLE OF VASCULAR HYPOPERFUSION, AND OXIDATIVE STRESS IN ALZHEIMER DISEASE (2007) (1)
DOES THE OXIDATIVE STRESS AND CEREBRAL ATHEROSCLEROSIS INITIATE BRAIN HYPOPERFUSION AND THE DEVELOPMENT OF ALZHEIMER DISEASE (2008) (1)
Whole-body and part-body turnover of 85Sr in Paget's decease (1983) (1)
P3-275 Phosphorylation dependent control of oxidative modification in Alzheimer disease (2004) (1)
ALTERED EXTRACELLULAR MATRIX (ECM)-CELL SIGNALING IN ALZHEIMER DISEASE (1999) (1)
NEUROFILAMENT HEAVY SUBUNIT (NFH) IS A SPECIFIC TARGET OF OXIDATIVE DAMAGE IN THE AXON (1998) (1)
P2-003 Cholesterol feeding enhances cerebral amyloid beta pathology in beagles (2004) (1)
SEQUESTRATION OF IRON BY LEWY BODIES IN PARKINSON DISEASE (1999) (1)
Dementia and testosterone levels in men. (2005) (1)
Neuronal Oxidative Stress is a Common Feature of Alzheimer’s and Parkinson’s Diseases (1998) (1)
Nanoparticle-iron Chelator Conjugates as Multifunctional Disease-modifying Drugs for Prevention and Treatment of Alzheimer’s Disease (2012) (1)
Oxidative Stress and Alzheimer Disease: Mechanisms and Therapeutic Opportunities (2011) (1)
Brain Composition: Age-Related Changes (2009) (1)
P3-317: Failure in the control of cell cycle causes neurodegeneration (2008) (1)
Immunoaffinity purification of A4-related proteins from Alzheimer's disease brain tissue (1989) (1)
The Fallacy of Amyloid and Cognition in Alzheimer’s Disease (2006) (1)
MITOTIC CATASTROPHY IN ALZHEIMER DISEASE (1998) (1)
A pilot study to measure changes in body composition in very obese women on hypocaloric diets. (1998) (1)
The Calibration of fibre optic probes used for light dosimetry measurements during photodynamic therapy (1995) (1)
Comparison of in-vivo body composition using two Lunar dual-energy X-ray absorptiometers. (1998) (1)
Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer’s brain (2013) (1)
Signal Transduction in Alzheimers Disease (2002) (1)
Sequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathy (2006) (1)
Antioxidant reversal of oxidative stress-induced memory deficits (1999) (1)
Neurodegenerative processes in Alzheimer's disease: an overview of pathogenesis with strategic biomarker potential (2011) (1)
REDOX-ACTIVE IRON IS ASSOCIATED WITH THE PATHOLOGICAL LESIONS IN ALZHEIMER DISEASE (1997) (1)
Unveiling "the switch" from aging to Alzheimer's disease with the senescence-accelerated mouse model (SAMP8) (2011) (1)
Abnormal mitochondrial dynamics in Alzheimer disease (2008) (1)
P1-266 The critical role of the ERK pathway in the pathogenesis of Alzheimer's disease (2004) (1)
Tractography of Infantile Nystagmus Syndrome (2011) (1)
Dangers of the amyloid-beta vaccination. (2002) (1)
Involvement of Complex Carbohydrate Chemistry in Alzheimer’s Disease (2005) (1)
Chronic Activation of g 2 AMPK Induces Obesity and Reduces b Cell Function (2016) (1)
Neuronal Survival and Death in Alzheimer Disease (2002) (1)
Legal Lobbying : How To Make Your Voice Heard (2013) (1)
Amyloid-Vaccination : Testing the Amyloid Hypothesis ? (2006) (1)
Challenging Views of Alzheimer's disease (2002) (1)
Social Working (1995) (1)
Abstract 1587: Conditional Overexpression of the Oncogene c-Myc Produces Hypertrophic Cardiomyopathy and Results in Mitochondrial Dysfunction at Complex I (2008) (0)
P1-351: A novel approach to diagnosis: Antigen-antibody disassociation in Alzheimer's disease (2008) (0)
Upcoming Meetings Related to Alzheimer's Disease. (2008) (0)
Enhanced Progenitor Cell Integration Following Transplantation of Progenitor Cell/MMP2- Polymer Constructs (2008) (0)
Faculty Opinions recommendation of Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. (2010) (0)
ADVANCED GLYCATION AND LIPID MODIFICATION OF ROSENTHAL FIBERS IN ALEXANDERʼS DISEASE (1997) (0)
Novel Purine‐Based Fluoroaryl‐1,2,3‐triazoles as Neuroprotecting Agents: Synthesis, Neuronal Cell Culture Investigations, and CDK5 Docking Studies. (2011) (0)
P1-417 Ectopic localization of phospho-Smad2 in the vulnerable neurons of Alzheimer’s disease (2006) (0)
SEGMENTAL ACCUMULATION OF ABNORMAL FILAMENTS IN NEURONAL PROCESSES OF ALZHEIMER DISEASE (1996) (0)
O3-04-07 Vascular and metabolic failure in Alzheimer disease (2004) (0)
Molecular Characterization of the ??/??PP Interaction: The Pathogenic Pathway? (1995) (0)
Oral Presentations OP01: Neurodegenerative Diseases (2008) (0)
P4-242 Oxidative damage in ferritin-induced neurodegeneration (2004) (0)
Faculty Opinions recommendation of Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. (2010) (0)
Astrocytes are sensitive indicators of hyperthermia-induced brain oedema in normal and in Cu nanoparticles treated rats (2012) (0)
Contents, Vol. 75, 1997 (1997) (0)
Faculty Opinions recommendation of Discovery of Atg5/Atg7-independent alternative macroautophagy. (2010) (0)
Mitochondrial Fragmentation Mediates MPP+ Toxicity in Neurons: Implications for Parkinson's Disease (2011) (0)
Latrepirdine (Dimebon™) modulate mitochondrial dynamics in AD cell models (2010) (0)
Therapeutic opportunities in Alzheimer disease: Current concepts (2009) (0)
A prompt gamma neutron activation analysis facility for in-vivo determination of total body nitrogen and chlorine. (1993) (0)
P1-369 Evidence of gonadotropin-induced steroidogenesis in Alzheimer’s disease (2006) (0)
Protein Misfolding in Alzheimer's Disease: Pathogenic or Protective? (2007) (0)
RNA Oxidation in Neurodegenerative Diseases: Sublethal Damage as a Mechanism for Chronic Degeneration (2008) (0)
The Inquisitor: A Novel (2012) (0)
Alzheimer's disease: Pathology vs etiology (2007) (0)
Intra-laboratory variations using dual-photon absorptiometry (1983) (0)
Astrin, a substrate of GSK3β is differentially expressed in AD compared to age-matched controls (2009) (0)
Metal Ions and Neurodegenerative Diseases Paolo Zatta, Editor. World Scientific Publishing Co. Pte. Ltd, Singapore, 2004, pp 400 (2004) (0)
MUSCLE CELL DEGENERATION OF THE POSTERIOR CEREBRAL ARTERY IN ALZHEIMER DISEASE (1996) (0)
O2-04-07 Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1 associated regulator of cyclin B, in Alzheimer disease (2004) (0)
The Importance of Histochemical Detection of Oxidative Damage in Tissue (2010) (0)
Transthyretin and Aβ in Alzheimer's disease (2010) (0)
Immunocytochemical Evidence That the ( 3-Protein Precursor Is an Integral Component of Neurofibrillary Tangles of Alzheimer ' s Disease (2014) (0)
O4-02-08 Mitochondrial autophagocytosis in Alzheimer disease (2006) (0)
Actin Disassembly is Mechanically Regulated in Spontaneously Fracturing Stress Fibers (2011) (0)
Carbonyl-Related Modification of Neurofilaments in Aizheimer Disease: 93 (1995) (0)
Nutritional Antioxidants, Vitamins, Cognition, and Neurodegenerative Disease (2004) (0)
Using biology to untie the Gordian knot of Alzheimer's disease (2011) (0)
Neuronal leptin resistance in Alzheimer's disease (2013) (0)
The primary pathogenetic role of vascular contains vasoactive substances, hypoperfusion, mitochondria failure and oxidative stress in aging and Alzheimer disease (2005) (0)
α1-CHYMOTRYPSIN AND α1-TRYPSIN IMMUNOLOCALIZE WITH NEUROFIBRILLARY TANGLES AND SENILE PLAQUES OF ALZHEIMER DISEASE (1993) (0)
S5-02-04 Cell cycle re-entry mediates Alzheimer-type changes in neurons in vitro (2006) (0)
Total body calcium, plasma, and urinary calcium and parathormone estimation in paraplegics mobilising in pneumatic orthoses (1985) (0)
Foreword: Challenging views of Alzheimer's disease – 2004 (2005) (0)
P4-166: Overexpression of amyloid precursor protein causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins (2008) (0)
VASCULAR HYPOPERFUSION AND MITOCHONDRIA ABNORMALITY INDUCE OXIDATIVE STRESS THAT APPEARED TO BE A KEY FACTOR FOR THE DEVELOPMENT OF ALZHEIMER DISEASE (2004) (0)
Oxidative Damage to RNA in Aging and Neurodegenerative Disorders (2012) (0)
Neuronal cell cycle re-entry as a neurotoxic mechanism of soluble amyloid oligomers in hippocampal slice cultures (2010) (0)
Alzheimer research forum live discussion: not dead yet: estrogen deserves another chance. (2006) (0)
Thinking Outside the Box in Alzheimer Disease Treatment (2011) (0)
Is Alzheimers Disease a Myth? When is Disease a Disease? (2009) (0)
Introduction: Imaging in Alzheimer's disease (2005) (0)
Edinburgh Research Explorer Dominant Role of the p110 beta Isoform of PI3K over p110 alpha in Energy Homeostasis Regulation by POMC and AgRP Neurons (2018) (0)
X chromosome premature centromere division in neurons of Alzheimer patients (2009) (0)
Short Communication f3PP and Tau Interaction A Possible Link between Amyloid and Neurofibrillary Tangles in Alzheimer's Disease (2007) (0)
Cell cycle dysregulation and neurodegenerative diseases (2007) (0)
Faculty Opinions recommendation of Amino-acid imbalance explains extension of lifespan by dietary restriction in Drosophila. (2010) (0)
ALTERATIONS OF CDK4 AND P16, CONTROL ELEMENTS OF THE CELL CYCLE, IN ALZHEIMER DISEASE (1997) (0)
Subject Index Vol. 94, 2008 (2008) (0)
Abstracts of the XVIIth International Congress of Neuropathology (ICN 2010). Salzburg, Austria. September 11-15, 2010. (2010) (0)
P4-162: LRRK2 in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies (2006) (0)
Lipid peroxidation markers are associated with granulovacuolar degeneration but not lipofuscin formation (2010) (0)
Cerebral hemorrhage and amytoid-β [3] (2003) (0)
Dementia and testosterone levels in men. Authors' reply (2005) (0)
Nonestrogen-based hormonal therapies for Alzheimer’s disease (2008) (0)
Alzheimer's Disease: Foreword (2004) (0)
Neuroprotective effects of hypoxic preconditioning on streptozotocin-induced animal model of sporadic Alzheimer's disease (2011) (0)
Temporal Primacy of Oxidative Stress in the Pathological Cascade of Alzheimer Disease (2005) (0)
Reply (1995) (0)
Measuring Aptamer Affinity with Kinexa (2019) (0)
Faculty of 1000 evaluation for Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. (2012) (0)
Metal Homeostasis and Its Relation to Oxidative Stress in Alzheimer’s Disease (2003) (0)
Faculty Opinions recommendation of Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. (2009) (0)
Fat-free mass, muscle bulk and strength in liver disease. (1998) (0)
P1-388 Failure of cytoplasmic-nuclear transport in Alzheimer’s disease (2006) (0)
Mo1191 Segmentation and Analysis of Brain MRIs of Human Premature Infants With Dysphagia Are Distinct (2015) (0)
Neural Circuit involved in Idiopathic Nystagmus Syndrome Based on fMRI (2009) (0)
The course of hepatic steatosis in mcad deficiency: 141 (1997) (0)
Faculty Opinions recommendation of Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila. (2010) (0)
Dissociated Aβ antibody level in newly diagnosed Alzheimer's disease: A population-based study (2009) (0)
Moral panics and social work: A response to David Pilgrim (2017) (0)
Dating, Relationships and Family Issues (2017) (0)
P3-375 Lipoic acid and N-acetyl cysteine protect against mitochondrial-related oxidative stress in fibroblasts from Alzheimer disease patients (2006) (0)
Doctoral Recital: 2012-10-29 - Mark Smith, alto and tenor saxophone (2012) (0)
Moral panics and beyond (2015) (0)
Book Alerts (2009) (0)
P3-372 Oxidative stress and prion protein mutations (2006) (0)
P3-306 Differential expression of metabotrophic glutamate receptors (MGlurs) in Alzheimer disease (2004) (0)
How can universities best select the right people for social work programmes (2016) (0)
Mark K. Smith: SOCIJALNA PEDAGOGIJA (2002) (0)
CIC AGEP Post Doctoral Mentoring (2014) (0)
Contents Vol. 4, 2006–2007 (2008) (0)
Gelato Federation : Global Partnerships Advancing Itanium (2007) (0)
Transcript of Live Discussion: The Cell Cycle in Alzheimer's Disease: Let's Unite Around Division (2003) (0)
Social work as social education (2009) (0)
Sustainable Farming with the Shaker Organic Gardens (2017) (0)
A framework for sustainable community garden development (2016) (0)
All-trans retinoic acid treatment of Alzheimer's disease transgenic mice (2011) (0)
EVIDENCE FOR OXIDATIVE STRESS IN PICKʼS DISEASE AND CORTICOBASAL DEGENERATION: 193 (1995) (0)
PREFRONTAL CORTEX TRANSCRIPTOME BY MULTIPLE RNA-SEQUENCING (2013) (0)
Ebolavirus-Induced Lymphocyte Apoptosis Mechanisms and Consequences of (0)
Extrapituitary expression of luteinizing hormone by human neurons possessing GnRH receptor 1 (2006) (0)
Subject Index Vol. 75, 1997 (1997) (0)
P4-423: Functional GnRH receptor signaling in neurons: Implications for the treatment of Alzheimer’s disease (2006) (0)
Oxidative Stress Associated Signal Transduction Cascades in Alzheimer Disease (2009) (0)
Mitochondrial Autophagocytosis in Alzheimer Disease (2007) (0)
Corticosteroids andbonemass inasthma: comparisons with rheumatoid arthritis andpolymyalgia rheumatica (1986) (0)
The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics (2007) (0)
Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass (2014) (0)
Analysis of intracellular amyloid‐β as a consistent feature of hippocampal neurons (2011) (0)
Comment on: "Basic investigations on the performance of a normoxic polymer gel with tetrakis-hydroxy-methyl-phosphonium chloride as an oxygen scavenger: reproducibility, accuracy, stability, and dose rate dependence" [Med. Phys. 33, 2506-2518 (2006)]. (2006) (0)
Foreword: Apoptotic Mechanisms in Neurodegenerative Diseases (2006) (0)
P4-421 EFFECTS OF SMALL ANIONIC SULFATES AND SULFONATES ON AMYLOID-BETA/HEPARAN SULFATE PROTEOGLYCAN (HSPG) INTERACTION IN AN IN VITRO MODEL OF AMYLOID DEPOSITION (2003) (0)
Can glycogen be measured by in vivo neutron activation analysis? (1992) (0)
Cell cycle aberrations mediate neurotoxicity induced by soluble amyloid-beta oligomers (2011) (0)
Abnormal activation of protein kinase C theta in Alzheimer's disease: Pathological implications (2010) (0)
Alzheimer research forum live discussion: Role and control of metal-mediated fibril toxicity (2005) (0)
P4-170: Peroxidative nitrotyrosine formation in Alzheimer's disease (2008) (0)
Asking the right questions [4] (1999) (0)
DLP1‐Dependent Mitochondrial Fragmentation Mediates 1‐methyl‐4‐phenylpyridinium (MPP+) Toxicity in Neurons (2011) (0)
Book Review:Neurodegeneration Methods and Protocols Jean Harry, Hugh A. Tilson (1999) (0)
Amyloid- _ and _ in Alzheimer’s Disease: What is the Neuropathology Trying to Tell Us? (2005) (0)
An In Vitro Model to Demonstrate Interactions of Neurons, Astrocytes, and Microglia with Alzheimer Senile Plaque Cores: 1 (1995) (0)
Commentary on “Perspective on a pathogenesis and treatment of Alzheimer’s disease.” Therapeutic strategies for Alzheimer’s disease: The need for a new era of innovation (2006) (0)
Specific reaction of Met 35 in amyloid beta peptide with hypochlorous acid (2010) (0)
Airway Smooth Muscle Resolidification Following Stretch Is Dependent On Zyxin (2012) (0)
INDUCTION OF NAPH CYTOCHROME P450 REDUCTASE BY AMYLOID β PROTEIN: FRIEND OR FOE OF NEURONS? (1999) (0)
O2-04-06 17β-Estradiol and luteinizing hormone modulate the expression of luteinizing hormone receptors in neuroblastoma cells (2004) (0)
P1-369 Modulation of cognition and amyloid load in the aged SWAβPP transgenic mouse by luprolide acetate, a GNRH agonist: targeting luteinizing hormone as a novel treatment for AD (2004) (0)
FTD and ADHD: Pathology versus pathophysiology (2001) (0)
P4-185: Mitochondrial dysfunction in Alzheimer's disease (2008) (0)
Exacerbation of amyloid beta peptide and Tau protein in the cerebrospinal fluid following Traumatic Brain Injury at Hot Environment. Neuroproetction by TiO2 nanowired delivery of cerebrolysin with tau antibodies (2018) (0)
Caloric Restriction Versus a Diet High in Antioxidants: Are they Equipotent in Altering or Reversing the Course of Aging? (2002) (0)
P4-250 Redox-active iron oxidizes ribosomal RNa in neurons vulnerable to Alzheimer's disease (2004) (0)
P3-369 Intraneuronal amyloid-β42 may silence oxidative stress in Alzheimer’s disease (2006) (0)
Role of Amyloid-beta in Alzheimer's Disease (2005) (0)
Involvement of gonadotropins in cognitive function: Implications for Alzheimer's disease (2009) (0)
Mechanosensitivity of Actin Turnover Allows Cells to Maintain Homeostasis against Myosin-II Contractile Fluctuations in the Cytoskeleton (2016) (0)
Modeling the heterogeneity in risk of progression to Alzheimer's disease acrosscognitive profiles in mild cognitive impairment (2013) (0)
P1-286 Glycogen synthase kinase-3β activity is regulated by products of lipid peroxidation: relevance to Alzheimer disease (2004) (0)
Green Tea (Camellia sinensis) Ameliorates Retinopathy and Renal Mitochondrial Defects but Deteriorates Collagen Glycoxidation and Cross‐Linking in Experimental Diabetes (2005) (0)
The Changing landscape of Alzheimer’s disease: From Insoluble to Soluble and from Pathogen to Protector (2006) (0)
EVIDENCE FOR WIDESPREAD PEROXYNITRITK-MF.DIATED DAMAGE IN ALZHEIMER DISEASE (1997) (0)
Alzheimer research forum discussion: Gain or loss of function - Time to shake up assumptions on γ-secretase in Alzheimer disease? Commentary (2007) (0)
Hydroxynonenal generated crosslinking fluorophores accumulate in Alzheimer's disease (2009) (0)
Chapter 19:Targeting Oxidative Mechanisms in Alzheimer Disease (2010) (0)
Disturbance in AMP-activated protein kinase (AMPK) signaling pathway in Alzheimer's disease (2010) (0)
Commentary Do Neurons Have a Choice in Death (2001) (0)
A theoretical analysis using ratios of the major elements measured by neutron activation analysis to derive total body water, protein, and fat. (1993) (0)
Bonemass innodalprimary generalised osteoarthrosis (1984) (0)
R-α-lipoic acid as a potent agent of mitochondrial protection in alzheimer’s disease (2012) (0)
Isotyping the human TOMM40 variable-length polymorphism by gene amplification and restriction digest. (2012) (0)
6th Conference of Neurodegenerative Disorders: Common Molecular Mechanisms, Tobago, West Indies (2001) (0)
Activation analysis by252californium for the estimation of the calcium content of bone (1976) (0)
Sir Martin Roth – A Debt of Gratitude (2007) (0)
Antibody‐Antigen Dissociation: A Novel Diagnostic Tool in Alzheimer Disease (2008) (0)
The effect of dialysate calcium concentration on 1alpha-hydroxyvitamin D3 on skeletal calcium loss and hyperparathyroidism in haemodialysis patients. (1977) (0)
P1-105: Neurodegeneration and iron overload in transgenic mice expressing a mutant form of the ferritin light polypeptide gene (2008) (0)
ALZHEIMER DISEASE IS MARKED BY A MAJOR SHIFT IN REDOX BALANCE (1999) (0)
Mitochondrial autophagocytosis in Alzheimer disease: 126.6 (2007) (0)
Decline in mitochondrial bioenergetics underlies central insulin resistance in streptozocin-induced model of sporadic Alzheimer's disease (2011) (0)
Professional Grant Writers [2] (multiple letters) (2004) (0)
Apoptosis Ebolavirus-Induced Lymphocyte Mechanisms and Consequences of (2010) (0)
Association of leptin receptor with neurofibrillary tangles of Alzheimer disease (2010) (0)
Journal of Alzheimer's disease established as a leading journal. (2001) (0)
Oxidative Adaptation in Aging and Alzheimer’s Disease: The Roles of Amyloid and Tau (2005) (0)
ALDEHYDE-MODIFICATION OF THE NEUROFILAMENT COMPONENT OF NEUROFIBRILLARY TANGLES IN ALZHEIMER DISEASE (1993) (0)
Giant Lipid Membranes Supported by Glass Beads for Membrane-Protein Interaction Studies (2018) (0)
Senile plaques and neurofibrillary tangles: The concurrent lesions of alzheimer's disease (1995) (0)
Metabolic and biochemical alterations in Alzheimer's disease: facts and fictions (2011) (0)
Association of mitochondrial signaling in Alzheimer's disease and hypoxia (2011) (0)
P3-229 P130, a regulator of the G1 phase of the cell cycle, in Alzheimer disease: Evidence of a stuttered cell cycle (2006) (0)
Symposium (2004) (0)
Total antioxidant status in newly diagnosed Alzheimer's patients: Population based study (2010) (0)
Oxidative Stress in Alzheimer Disease: The Earliest Cytological and Biochemical Feature (2004) (0)
EFFECT OF CHRONIC EXPRESSION OF HEME OXYGENASE-1 IN NEURONAL CELLS: RELEVANCE TO NEURODEGENERATIVE DISEASES (1997) (0)
CDK11/pitslre protein kinase is differentially expressed in hippocampus of Alzheimer patients (2009) (0)
Cell Cycle Activation and the Amyloid-β Protein in Alzheimer’s Disease (2006) (0)
Leave the good amyloid β alone [3] (2004) (0)
Neuropathology of Dementing Disorders: Edited by William R. Markesbery, Arnold, London, 1998. 316 pages, Price £125, ISBN: 0-34059-037-8 (2002) (0)
Contents Vol. 94, 2008 (2008) (0)
Mitochondria Dynamics Abnormalities in Alzheimer Disease (2009) (0)
Neurodegenerative Phenotypes Induced by MYC‐Driven Neuronal Cell Cycle Re‐entry: Relevance to Alzheimer Disease (2008) (0)
Increased oxidative stress involving olfactory neurons in Alzheimer disease (2000) (0)
Book review (2007) (0)
Oxidative Stress in Aging and Neurodegenerative Diseases: From Biology to Therapy, Perugia, Italy, May 2003 (2004) (0)
Neurogenesis in Alzheimer’s Disease (2006) (0)
Phosphorylation, Microtubule Binding and Aggregation of Tau Protein in Alzheimer's Disease (2002) (0)

This paper list is powered by the following services:

Other Resources About Mark A. Smith

What Schools Are Affiliated With Mark A. Smith?

Mark A. Smith is affiliated with the following schools:

Mark A. Smith's Academic­Influence.com Rankings